Monthly Archives: December 2017

Free Post Earnings Research Report: Coty’s Revenue Soared 107.21%

LONDON, UK / ACCESSWIRE / December 26, 2017 / Active-Investors.com has just released a free earnings report on Coty Inc. (NYSE: COTY). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=COTY. Coty posted its first quarter fiscal 2018 (Q1 FY18) results on November 09, 2017. The leading cosmetics provider outperformed top- and bottom-line expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Coty most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=COTY

Earnings Highlights and Summary

In Q1 FY18, Coty revenues surged 107.21% to $2.24 billion in Q1 FY18 compared to $1.08 billion in Q1 FY17. Revenue numbers topped analysts’ estimates of $2.22 billion.

The Company’s gross profit was $1.36 billion in the reported quarter compared to $635.40 million in Q1 FY17, reflecting a growth of 114.67%.

Coty’s operating income was $28.70 million in Q1 FY18 compared to $46.40 million in Q1 FY17, reflecting a decline of 38.14% y-o-y.

The Company posted net loss of $16.10 million in Q1 FY18 compared to a net income of $9.80 million in Q1 FY17. The diluted loss in the reported quarter was $0.03 per share. Adjusted earnings were $0.10 per share in the reported quarter, beating analysts’ estimates of $0.07 per share.

Coty’s Segment Details

Coty has three business segments, namely: (i) Luxury; (ii) Consumer Beauty; and (iii) Professional Beauty.

Revenues for its Luxury segment surged 70.24% to $764.40 million in Q1 FY18 compared to $449.00 million in Q1 FY17, due to acquisition of P&G’s beauty business in 2016 and momentum in Hugo Boss, Gucci, and Tiffany and Co. The segment’s operating income was $56.70 million in the reported quarter compared to $75.70 million in Q1 FY17, declining 25.09% on a y-o-y basis.

The Consumer Beauty segment’s revenues surged 82.44% to $1.04 billion in Q1 FY18 compared to $571.90 million in Q1 FY17, due to the Company’s acquisition of Younique and P&G beauty business. The segment’s operating income was $61.90 million in Q1 FY18 compared to $53.20 million in Q1 FY17, advancing 16.35% on a y-o-y basis.

The Professional Beauty segment’s revenues were $430.50 million in Q1 FY18 compared to $59.30 million in Q1 FY17, due to acquisition of ghd and P&G’s beauty business. The segment’s operating loss was $1.70 million in the reported quarter compared to an operating income of $16.30 million in Q1 FY17.

Region-wise, net revenues surged over 100.00% across North America and Europe due to the acquisition of Younique and ghd. Sales in the ALMEA region jumped 74.00% on a reported basis.

Cash Matters

Coty had cash and cash equivalents of $944.60 million on September 30, 2017, compared to $403.00 million on September 30, 2016. The Company had net outflow from operating activities of $8.90 million in Q1 FY18 compared to a net outflow of $6.00 million in Q1 FY17. On August 22, 2017, Coty declared quarterly cash dividend of $0.125 per share, paid on September 14, 2017, to shareholders on record date of September 01, 2017. The Company also declared a dividend of $0.125 per share to be paid on December 14, 2017, to shareholders of record as of November 30, 2017.

Outlook

For second quarter fiscal 2018 (Q2 FY18), Coty anticipates earnings of $0.23 per share and for third quarter fiscal 2018 (Q3 FY18), Coty anticipates earnings of $0.16 per share.

Stock Performance Snapshot

December 22, 2017 – At Friday’s closing bell, Coty’s stock marginally advanced 0.91%, ending the trading session at $19.93.

Volume traded for the day: 2.05 million shares.

Stock performance in the last month – up 17.37%; previous three-month period – up 22.72%; past twelve-month period – up 6.41%; and year-to-date – up 8.85%

After last Friday’s close, Coty’s market cap was at $14.80 billion.

The stock has a dividend yield of 2.51%.

The stock is part of the Consumer Goods sector, categorized under the Personal Products industry. This sector was flat at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484899

EX-Dividend Schedule: Cypress Semiconductor has a Dividend Yield of 2.78%; Will Trade Ex-Dividend on December 27, 2017

LONDON, UK / ACCESSWIRE / December 26, 2017 / Active-Investors has a free review on Cypress Semiconductor Corp. (NASDAQ: CY) following the Company’s announcement that it will begin trading ex-dividend on December 27, 2017. To capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on December 26, 2017. Active-Investors has initiated due-diligence on this dividend stock. Register with us for more free research including the one on CY:

www.active-investors.com/registration-sg/?symbol=CY

If your portfolio includes dividend stocks, you have come to the right place for timely information. All you need to do is sign up for your free membership at:

www.active-investors.com/registration-sg

Dividend Declared

On November 08, 2017, Cypress Semiconductor announced that its Board of Directors has approved a quarterly cash distribution of $0.11 per share payable to holders of record of the Company’s common stock at the close of business on December 28, 2017. This dividend will be paid on January 18, 2018.

Cypress Semiconductor’s indicated dividend represents a yield of 2.78%, which is more than double the average dividend yield of 1.24% for the Utilities sector.

Dividend Insights

Cypress Semiconductor has a dividend payout ratio of 78.6%, which denotes that the Company spends approximately $0.79 for dividend distribution out of every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts’ estimates, Cypress Semiconductor is forecasted to report earnings of $1.19 per share for the next year, which is substantially above the Company’s annualized dividend of $0.44 per share.

As of October 01, 2017, Cypress Semiconductor’s cash and cash equivalents totaled $131.56 million compared to $121.14 million as on January 01, 2017. For the three months ended October 01, 2017, the Company’s net cash provided by operating activities totaled $143.78 million compared to $32.45 million for the year ago same period. The Company’s strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain the dividend distribution for a long period.

Recent Development for Cypress Semiconductor

On December 18, 2017, Cypress Semiconductor announced the appointment of Jeannine Sargent to its Board of Directors. Sargent brings 30 years of experience encompassing leadership, operations, marketing, and engineering roles within a diverse mix of high tech component and systems companies across multiple industries. As part of her responsibilities on Cypress Semiconductor’s Board, she will serve on the Company’s Compensation Committee.

In her most recent role as President of Innovation and New Ventures at Flex, a leading contract design, engineering and manufacturing Company, Sargent led the fastest growing and highest margin design-enabled business. Prior to this, she served as president of Flex’s Energy business, which she helped build into a global multi-billion-dollar industry leader focusing on renewable energy, smart grid and solid-state lighting technologies, products and services. In her career, Sargent has served as CEO at both Oerlikon Solar, a thin-film silicon solar photovoltaic (PV) module manufacturer, and Voyan Technology, an embedded systems software provider to the communications and semiconductor industries.

About Cypress Semiconductor Corp.

Cypress Semiconductor is the leader in advanced embedded system solutions for the world’s most innovative automotive, industrial, smart home appliances, consumer electronics, and medical products. The Company’s microcontrollers, analog ICs, wireless, and USB-based connectivity solutions and reliable, high-performance memories help engineers design differentiated products and get them to market first.

Stock Performance Snapshot

December 22, 2017 – At Friday’s closing bell, Cypress Semiconductor’s stock slightly declined 0.46%, ending the trading session at $15.31.

Volume traded for the day: 7.30 million shares, which was above the 3-month average volume of 5.83 million shares.

Stock performance in the last three-month – up 8.05%; previous six-month period – up 13.66%; past twelve-month period – up 31.30%; and year-to-date – up 33.83%

After last Friday’s close, Cypress Semiconductor’s market cap was at $5.13 billion.

The stock has a dividend yield of 2.87%.

The stock is part of the Technology sector, categorized under the Semiconductor – Broad Line industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484900

Free Research Report as D.R. Horton’s Revenue Jumped 12% and EPS Advanced 10%

Stock Monitor: Hovnanian Enterprises Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 26, 2017 / Active-Investors.com has just released a free earnings report on D.R. Horton, Inc. (NYSE: DHI) (“Horton”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=DHI. The Company reported its fourth quarter fiscal 2017 operating results on November 09, 2017. The homebuilder completed its 16th year in a row as the largest homebuilder by volume in the United States, and reported better than expected revenue and earnings. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Hovnanian Enterprises, Inc. (NYSE: HOV), which also belongs to the Industrial Goods sector as the Company D.R. Horton. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=HOV

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, D.R. Horton most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=DHI

Earnings Highlights and Summary

For the three months ended September 30, 2017, Horton’s revenue totaled $4.07 billion compared to $3.65 billion for Q4 FY16. The Company’s revenue numbers topped analysts’ estimates of $4.04 billion.

During Q4 FY17, Horton’s Homebuilding revenue jumped 11% to $4.1 billion from $3.7 billion in Q4 FY16. The Company’s homes closed increased 7% to 13,165 homes in the reported quarter compared to 12,247 homes in the year-earlier same quarter. For FY17, Horton’s Homebuilding revenue increased 16% to $13.7 billion from $11.9 billion in FY16.

For Q4 FY17, Horton’s net sales orders grew 18% to 10,333 homes from 8,744 homes in the year-ago comparable quarter, and the value of net sales orders increased 19% to $3.1 billion from $2.6 billion. The Company’s cancellation rate was 25% for the reported quarter.

At September 30, 2017, Horton’s Homes in inventory increased 13% to 26,200 homes compared to 23,100 homes at September 30, 2016. At September 30, 2017, the Company’s land and lot portfolio consisted of 249,000 lots, of which 50% were owned and 50% were controlled through option contracts, compared to 205,000 lots at September 30, 2016, of which 55% were owned and 45% were controlled through option contracts.

Horton’s Homebuilding return on inventory (ROI) improved 120 basis points to 16.6% in FY17 from 15.4% in FY16.

Horton’s net income jumped 10% to $313.2 million, or $0.82 per diluted share, for Q4 FY17 compared to $283.6 million, or $0.75 per diluted share, in Q4 FY16. The Company’s earnings met Wall Street’s estimates of $0.82 per share. For FY17, the Company’s net income increased 17% to $1.0 billion, or $2.74 per diluted share, compared to $886.3 million, or $2.36 per diluted share, in FY16.

Cash Matters

Horton’s net cash provided by operations was $435.1 million for FY17, and the Company ended the year with $973.0 million of Homebuilding unrestricted cash and Homebuilding debt to total capital of 24.0%.

Guidance for FY18

For FY18, Horton is forecasting a consolidated pre-tax profit margin of 11.5% to 11.7%, and consolidated revenues in the band of $15.5 billion to $16.3 billion. The Company is projecting Homes closed between 50,500 homes and 52,500 homes, and a home sales gross margin of approximately 20%. The Company is also expecting Homebuilding SG&A as a percentage of homebuilding of revenues of around 8.7%. Horton is estimating cash flow from operations to be of at least $500 million.

Stock Performance Snapshot

December 22, 2017 – At Friday’s closing bell, D.R. Horton’s stock slightly fell 0.20%, ending the trading session at $50.83.

Volume traded for the day: 2.36 million shares.

Stock performance in the last month – up 2.52%; previous three-month period – up 37.08%; past twelve-month period – up 83.11%; and year-to-date – up 85.99%

After last Friday’s close, D.R. Horton’s market cap was at $19.10 billion.

Price to Earnings (P/E) ratio was at 18.56.

The stock has a dividend yield of 0.98%.

The stock is part of the Industrial Goods sector, categorized under the Residential Construction industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484901

Blog Exposure – Gemphire Therapeutics Launches Clinical Program for Developing Gemcabene as Treatment for NASH/NAFLD

LONDON, UK / ACCESSWIRE / December 26, 2017 / Active-Investors.com has just released a free research report on Gemphire Therapeutics Inc. (NASDAQ: GEMP). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=GEMP as the Company’s latest news hit the wire. On December 21, 2017, the Company announced the launch of a clinical program to develop its drug candidate – Gemcabene – as a treatment option for NASH/non-alcoholic fatty liver disease (NAFLD). An Investigational New Drug (IND) application has been opened by the Company for non-alcoholic steatohepatitis (NASH). Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Gemphire Therapeutics most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=GEMP

This program is where the Company will start the Phase-IIa proof-of-concept (POC) clinical trials in adult candidates with FPL (familial partial lipodystrophy). FPL is a rare genetic disorder and orphan disease where patients have an abnormal distribution of fatty (adipose) tissue, which can lead to a variety of metabolic abnormalities including NASH.

Commenting on the launch of the Phase-IIa clinical program, Dr. Steven Gullans, Interim CEO of Gemphire, said:

“We are very pleased to initiate this clinical trial as the first step in our plan to develop Gemcabene as a highly differentiated treatment for NASH. As the only compound in development that targets the triple threat of LDL-C, inflammation and triglycerides (TG) – addressing the full spectrum of dyslipidemia – we believe Gemcabene has potential to be highly effective in this adult population, which is burdened by multiple cardiometabolic risk factors.”

About Phase-IIa POC clinical trial

The Company is confident about the success of its clinical program as it is based on the strong preclinical data and scientific rationale that support the use of Gemcabene for treatment of NASH. Gemcabene has a novel action mechanism which the Company believes has a significant potential to establish the effects of the drug on established measures of NASH that can also be evaluated in FPL patients. Additionally, that Company plans to launch the second part of the Phase-IIa POC trials in NASH in Q1 2018. The aim of these trials is to make way for confirmatory trials in a broader NASH population.

The Phase-IIa POC clinical trial is aimed at measuring NASH-related endpoints in FPL. The main objective of these trials is to evaluate the efficacy and safety of two dosing regimens of Gemcabene in up to eight FPL patients with elevated TG (triglycerides) and NAFLD. When entering the trials, the candidates must have a fasting TG value ≥ 250 mg/dL and quantifiable steatosis (stage 2 or 3) while on a stable, low-fat, low-cholesterol diet. After which they will be split into two random groups for treatment where they will either receive a dosage of Gemcabene 300 mg once daily for 24 weeks or a dosage of Gemcabene 300 mg once daily for 12 weeks. This will immediately be followed by a dosage of Gemcabene 600 mg once daily for a further 12 weeks.

The endpoint of the clinical trial is the reduction in TG after 12 weeks of treatment. The second endpoint is to include measures of liver fat (MRI-PDFF) and NAS (histology) at 24 weeks. Those patients who respond to the treatment and show TG lowering > 30% at Week 12, will have a chance to enter a separate long-term therapy with Gemcabene. The Company is expecting to meet its endpoint and share the results in H2 2018.

Rationale for Going ahead with Gemcabene clinical trials

The Company’s decision to move forward with Gemcabene is mainly because of this novel mechanism of action in NASH. Gemcabene has both liver- and cardio-protective properties. Gemcabene’s compound targets the pathology of the disease and has the potential to add complementary mechanisms that lower both TG (fat) and inflammation. The Company has compiled data on Gemcabene from over 950 subjects across 20 completed trials. The studies also show that subjects treated with oral, once-daily Gemcabene, have significant lowering in plasma of atherogenic particles, TG and CRP (a measure of inflammation). Gemcabene has also demonstrated a doubling of mean increase in glucose disposal rate compared to placebo suggesting potential effects on insulin sensitivity.

The data shows that Gemcabene is well tolerated and does not show any liver toxicities at doses between 150 mg to 900 mg for up to 12 weeks. the data also indicated that Gemcabene has a low likelihood for drug-drug interactions, particularly with statins. This is crucial since statins are widely used in diabetic and dyslipidemic patients, the underlying conditions associated with NASH. Gemcabene’s safety profile indicated that it has a competitive advantage in the treatment of NASH/NALFD.

About Familial Partial Lipodystrophy

FPL is a rare genetic disorder and an orphan disease characterized by an abnormal distribution of fatty (adipose) tissue. As the body is unable to store fat correctly, a build-up can occur around all vital organs and in the blood (hypertriglyceridemia). FPL can also cause an abnormal build-up of fats in the liver (hepatic steatosis), which can result in an enlarged liver (hepatomegaly) and abnormal liver function. FPL can lead to loss of metabolic control and a variety of metabolic abnormalities including diabetes, cardiovascular disease, hypertriglyceridemia and NASH. At present there is no FDA approved treatment for FPL Lipodystrophy United, an organization with the mission to provide an interactive community, facilitate support and education for anyone affected by this rare disease is supporting this potential treatment.

About NAFLD/NASH

NASH is a severe disease of the liver caused by inflammation and a build-up of fat in the organ. It is estimated that approximately 2% to 5% of the adult population in US is affected by NASH. In addition, another 10% to 30% of the population has fat in their liver, but no inflammation or liver damage, this condition is called NAFLD or “fatty liver”. The factors causing NASH are unclear, however, the condition occurs in middle-aged and overweight or obese people. Progression of NAFLD/NASH can lead to liver cirrhosis, fibrosis, hepatocellular carcinoma, liver failure, and liver-related death. Currently, there are no FDA approved treatments for NAFLD/NASH.

About Gemcabene

The Company’s drug candidate Gemcabene is a first-in-class, once-daily, oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with currently approved therapies, primarily statins. The unique feature of Gemcabene is its mechanism of action and safety profile, which are highly differentiated from other clinical candidates. Gemcabene’s mechanism of action (MOA) is designed to enhance the clearance of very low-density lipoproteins (VLDLs) in the plasma and inhibition of the production of cholesterol and triglycerides in the liver. Gemcabene has demonstrated POC efficacy for NASH in the rodent STAM™ model developed at SMC Laboratories in Tokyo, Japan. Gemcabene has been tested as monotherapy and in combination with statins and other drugs in 956 subjects across 20 Phase-1 and Phase-2 clinical trials. Given the above efficacy and safety and tolerability profile, Gemcabene has potential for treatment of humans, especially when used as an add-on to several other therapeutic drugs.

About Gemphire Therapeutics Inc.

Livonia, Michigan based Gemphire is a clinical-stage biopharmaceutical Company focused on developing and commercializing therapies for the treatment of dyslipidemia and NASH. The Company is focused on providing new treatment options for cardiometabolic diseases through its complementary, convenient, cost-effective product candidate Gemcabene as add-on to the standard of care, especially statins, that will benefit patients, physicians, and payors.

Stock Performance Snapshot

December 22, 2017 – At Friday’s closing bell, Gemphire Therapeutics’ stock advanced 3.30%, ending the trading session at $8.13.

Volume traded for the day: 25.63 thousand shares.

Stock performance in the last twelve-month period – up 2.39%; and year-to-date – up 3.70%

After last Friday’s close, Gemphire Therapeutics’ market cap was at $83.74 million.

The stock is part of the Healthcare sector, categorized under the Biotechnology industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484902

In Digital Marketing Reputation Marketing is Key for Local Businesses says Firm

Clearwater digital marketing agency Online Station launched an update of its popular reputation marketing and lead generation service. The company helps businesses improve their market reach and online authority by being featured on high-quality media websites such as ABC, CBS, NBC and FOX affiliates.

Clearwater, United States – December 26, 2017 /NewsNetwork/ —

Online Station, a full-service digital marketing agency based in Clearwater, Florida, launched an updated range of solutions for companies looking to improve their market reach, boost their online reputation and connect with more clients. The company partners with professional brand journalists and media agencies to create high-authority media campaigns for business clients in all industries.

More information can be found at http://onlinestationllc.com.

Recent years have seen more and more businesses invest significant resources in developing a reputable digital presence, as the vast majority of consumers have become accustomed to using search engines, social media platforms and other online services to find information on local companies.

Online Station is a professional digital marketing agency specializing in high-efficiency media relations and reputation marketing services. The company has recently announced an update of its services, offering businesses the chance to be featured on high-quality media websites.

The company works with professional brand journalists to create custom news pieces for its client businesses. Each article is based on the client’s specific brand profile, helping them promote their product launches, service updates, events and other brand-related news in an effective, brand-appropriate manner.

Online Station ensures that each article is published on more than 300 high-quality media websites, including CBS, ABC, NBC and FOX affiliates. This wide media coverage offers immediate benefits in terms of online reputation, companies being able to showcase their broad media presence on their own websites or on social media networks.

Additionally, the new marketing service from Online Station is also important in terms of SEO. Since each article contains a link back to the company’s official website, a single media campaign can result in more than 300 high-quality backlinks. The Clearwater marketing agency works with SEO experts to ensure that the articles are optimized for the client’s target keywords to yield additional SEO benefits.

Online station currently provides a free market analysis available at http://onlinestationllc.com/online-presence.

Interested parties can find more information by visiting the above-mentioned website.

Contact Info:
Name: Lee Wilson
Email: Send Email
Organization: Online Station LLC
Address: 611 South Fort Harrison Avenue #172, Clearwater, Florida 33756, United States
Phone: +1-727-639-2719

For more information, please visit http://onlinestationllc.com/

Source: NewsNetwork

Release ID: 281351

Internet of Things Security Market and Internet of Things Twin Market Predictable to Witness Sustainable Evolution over 2022

New Study on “Global Internet of Things (IoT) Security Market” & “Global Internet of Things (IoT) Twin Market” added to OrbisResearch.com database.

Dallas, United States – December 26, 2017 /MarketersMedia/ —

“Global Internet of Things (IoT) Security Market Size, Status and Forecast 2022” and “Global Internet of Things (IoT) Twin Market Size, Status and Forecast 2022” provides, wherever applicable and relevant, technical data of products, and sheds useful light on expected commercial production dates and current R&D status. This report will help the viewer in Better Decision Making.

Summary (Global Internet of Things (IoT) Security Market):
This report studies the global Internet of Things (IoT) Security market, analyzes and researches the Internet of Things (IoT) Security development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

Request a sample for “Global Internet of Things (IoT) Security Market” @ http://orbisresearch.com/contacts/request-sample/469060 .

This report focuses on the top players in global market, like:
1. Geographic Revenue Mix
2. Cisco Systems,Inc
3. BM Corporation
4. Infineon Technologies
5. Intel Corporation
6. Symantec Corporation
7. Arm Holdings PLC
8. Check Point Software Technologies Ltd
9. Trend Micro,Inc
10. PTC,Inc
..Continued

Browse the Report “Global Internet of Things (IoT) Security Market” @ http://orbisresearch.com/reports/index/global-internet-of-things-iot-security-market-size-status-and-forecast-2022 .

Market segment by Regions/Countries, this report covers:
• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Internet of Things (IoT) Security can be split into:
• Network Security
• Endpoint Security
• Application Security
• Cloud Security
• Others

Market segment by Application, Internet of Things (IoT) Security can be split into:
• Wearables
• Building and Home Automation
• Supply Chain Management
• Patient Information Management
• Energy and Utilities Management
• Customer Information Security

If you have any special requirements, please let us know and we will offer you the report as you want.

Buy “Global Internet of Things (IoT) Security Market” @ http://orbisresearch.com/contact/purchase/469060 .

Major Points from TOC for “Global Internet of Things (IoT) Security Market”:
1. Industry Overview of Internet of Things (IoT) Security
2. Global Internet of Things (IoT) Security Competition Analysis by Players
3. Company (Top Players) Profiles
4. Global Internet of Things (IoT) Security Market Size by Type and Application (2012-2017)
5. United States Internet of Things (IoT) Security Development Status and Outlook
6. EU Internet of Things (IoT) Security Development Status and Outlook
7. Japan Internet of Things (IoT) Security Development Status and Outlook
8. China Internet of Things (IoT) Security Development Status and Outlook
9. India Internet of Things (IoT) Security Development Status and Outlook
10. Southeast Asia Internet of Things (IoT) Security Development Status and Outlook
11. Market Forecast by Regions, Type and Application (2017-2022)
12. Internet of Things (IoT) Security Market Dynamics
13. Market Effect Factors Analysis
14. Research Finding/Conclusion
15. Appendix

Summary (Global Internet of Things (IoT) Twin Market):
This report studies the global Internet of Things (IoT) Twin market, analyzes and researches the Internet of Things (IoT) Twin development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

Request a sample for “Global Internet of Things (IoT) Twin Market” @ http://orbisresearch.com/contacts/request-sample/2000617 .

This report focuses on the top players in global market, like:
1. General Electric
2. PTC
3. Siemens
4. Dassault Systèmes
5. IBM Corporation
6. ANSYS
..Continued

Browse the Report “Global Internet of Things (IoT) Twin Market” @ http://orbisresearch.com/reports/index/global-internet-of-things-iot-twin-market-size-status-and-forecast-2022 .

Market segment by Regions/Countries, this report covers:
• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into:
• Parts Type
• System Type

Market segment by Application, Internet of Things (IoT) Twin can be split into:
• Aerospace & Defense
• Automotive & Transportation
• Machine Manufacturing
• Energy & Utilities
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Buy “Global Internet of Things (IoT) Twin Market” @ http://orbisresearch.com/contact/purchase/2000617 .

Major Points from TOC for “Global Internet of Things (IoT) Twin Market”:
1. Industry Overview of Internet of Things (IoT) Twin
2. Global Internet of Things (IoT) Twin Competition Analysis by Players
3. Company (Top Players) Profiles
4. Global Internet of Things (IoT) Twin Market Size by Type and Application (2012-2017)
5. United States Internet of Things (IoT) Twin Development Status and Outlook
6. EU Internet of Things (IoT) Twin Development Status and Outlook
7. Japan Internet of Things (IoT) Twin Development Status and Outlook
8. China Internet of Things (IoT) Twin Development Status and Outlook
9. India Internet of Things (IoT) Twin Development Status and Outlook
10. Southeast Asia Internet of Things (IoT) Twin Development Status and Outlook
11. Market Forecast by Regions, Type and Application (2017-2022)
12. Internet of Things (IoT) Twin Market Dynamics
13. Market Effect Factors Analysis
14. Research Finding/Conclusion
15. Appendix

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL: https://marketersmedia.com/internet-of-things-security-market-and-internet-of-things-twin-market-predictable-to-witness-sustainable-evolution-over-2022/281592

For more information, please visit http://www.orbisresearch.com

Source: MarketersMedia

Release ID: 281592

Global Vessel Traffic Services (VTS) Market 2017 Size, Share, Growth, Trends, Type, Application, Analysis and Forecast by 2022

WiseGuyReports.com adds “Vessel Traffic Services (VTS) Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database.

Pune, India – December 26, 2017 /MarketersMedia/ —

Vessel Traffic Services (VTS) Market:

Executive Summary

The report provides a comprehensive analysis of the Vessel Traffic Services (VTS) industry market by types, applications, players and regions. This report also displays the production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Vessel Traffic Services (VTS) industry in USA, EU, China,India, Japan and other regions, and forecast to 2022, from 2017.

Market Analysis by Players

Signalis
Indra Company
Saab
Kongsberg
Transas
Lockheed Martin
keiki
Frequentis
Vissim AS
SRT

Request Sample Report @ https://www.wiseguyreports.com/sample-request/2674787-2017-global-vessel-traffic-services-vts-industry-research-report

Market Analysis by Regions:

USA
Europe
Japan
China
India
Southeast Asia
South America
South Africa
Others

Market Analysis by Types:

INS and NAS
TOS
Others

Market Analysis by Applications:

Port Service
Coastal Service
Others

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/2674787-2017-global-vessel-traffic-services-vts-industry-research-report

Table of content:

1 Vessel Traffic Services (VTS) Market Overview 
    1.1 Product Overview of Vessel Traffic Services (VTS) 
    1.2 Classification and Application of Vessel Traffic Services (VTS) 
    1.3 Global Vessel Traffic Services (VTS) Market Regional Analysis 
      1.3.1 USA Market Present Situation Analysis 
      1.3.2 Europe Market Present Situation Analysis 
      1.3.3 Japan Market Present Situation Analysis 
      1.3.4 China Market Present Situation Analysis 
      1.3.5 India Market Present Situation Analysis 
      1.3.6 Southeast Asia Market Present Situation Analysis 
      1.3.7 South America Market Present Situation Analysis 
      1.3.8 South Africa Market Present Situation Analysis 
    1.4 Vessel Traffic Services (VTS) Industry Development Factors Analysis 
      1.4.1 Vessel Traffic Services (VTS) Industry Development Opportunities Analysis 
      1.4.2 Vessel Traffic Services (VTS) Industry Development Challenges Analysis 
    1.5 Vessel Traffic Services (VTS) Consumer Behavior Analysis 

2 Global Vessel Traffic Services (VTS) Competitions by Players 
    2.1 Global Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Players 
    2.2 Global Vessel Traffic Services (VTS) Revenue (Million USD) and Share by Players (2016-2017) 
    2.3 Global Vessel Traffic Services (VTS) Price (USD/Unit) by Players (2016-2017) 
    2.4 Global Vessel Traffic Services (VTS) Gross Margin by Players (2016-2017) 

3 Global Vessel Traffic Services (VTS) Competitions by Types 
    3.1 Global Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Types 
    3.2 Global Vessel Traffic Services (VTS) Revenue (Million USD) and Share by Type (2012-2017) 
    3.3 Global Vessel Traffic Services (VTS) Price (USD/Unit) by Type (2012-2017) 
    3.4 Global Vessel Traffic Services (VTS) Gross Margin by Type (2012-2017) 
    3.5 USA Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
    3.6 China Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
    3.7 Europe Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
    3.8 Japan Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
    3.9 India Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
    3.10 Southeast Asia Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
    3.11 South America Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
    3.12 South Africa Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Type 
4 Global Vessel Traffic Services (VTS)Competitions by Application 
    4.1 Global Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.2 Global Vessel Traffic Services (VTS) Revenue (Million USD) and Share by Application (2012-2017) 
    4.3 Global Vessel Traffic Services (VTS) Price (USD/Unit) by Application (2012-2017) 
    4.4 Global Vessel Traffic Services (VTS) Gross Margin by Application (2012-2017) 
    4.5 USA Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.6 China Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.7 Europe Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.8 Japan Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.9 India Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.10 Southeast Asia Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.11 South America Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 
    4.12 South Africa Vessel Traffic Services (VTS) Sales (Unit) and Market Share (%) by Application 

5 Global Vessel Traffic Services (VTS) Production Market Analysis by Region 
    5.1 Global Vessel Traffic Services (VTS) Production (Unit) and Market Share (%) by Region 
    5.1.1USA Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
      5.1.2 Europe Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
      5.1.3 China Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
      5.1.4 Japan Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
      5.1.5 India Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
      5.1.6 Southeast Asia Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
      5.1.7 South America Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
      5.1.8 South Africa Vessel Traffic Services (VTS) Market Production Present Situation Analysis 
    5.2 Global Vessel Traffic Services (VTS) Production Value (Million USD) and Share by Region (2012-2017) 
    5.3 Global Vessel Traffic Services (VTS) Price (USD/Unit) by Region (2012-2017) 
    5.4 Global Vessel Traffic Services (VTS) Gross Margin by Region (2012-2017) 

6 Global Vessel Traffic Services (VTS) Sales Market Analysis by Region 
    6.1 USA Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 
    6.2 Europe Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 
    6.3 China Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 
    6.4 Japan Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 
    6.5 India Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 
    6.6 Southeast Asia Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 
    6.7 South America Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 
    6.8 South Africa Vessel Traffic Services (VTS) Market Consumption Present Situation Analysis 

7 Imports and Exports Market Analysis 
    7.1 USA Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017) 
    7.2 Europe Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017) 
    7.3 China Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017) 
    7.4 Japan Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017) 
    7.5 India Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017) 
    7.6 Southeast Asia Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017) 
    7.7 South America Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017) 
    7.8 South Africa Vessel Traffic Services (VTS) Imports and Exports Analysis (2012-2017)      

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2674787

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: Wise Guy Research Consultants Pvt Ltd
Address: Office No. 528, Amanora Chambers Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349 (US); +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/global-vessel-traffic-services-vts-market-2017-size-share-growth-trends-type-application-analysis-and-forecast-by-2022/281599

For more information, please visit https://www.wiseguyreports.com/reports/2674787-2017-global-vessel-traffic-services-vts-industry-research-report

Source: MarketersMedia

Release ID: 281599

Drugs for Malaria Market 2017 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast to 2022

Wiseguyreports.Com adds “Drugs for Malaria Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Pune, India – December 26, 2017 /MarketersMedia/ —

Drugs for Malaria Market 2017

Wiseguyreports.Com adds “Drugs for Malaria Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

This report provides in depth study of “Drugs for Malaria Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Drugs for Malaria Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Drugs for Malaria industry.

Major Companies 
Cipla 
Guilin Pharmaceutical 
IPCA Laboratories 
GlaxoSmithKline 
Mylan Labs 
Roche 
Novartis 
Sanofi Aventis 
Ajanta Pharma

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2674823-global-and-united-states-drugs-for-malaria-in-depth-research-report-2017-2022

Key Regions 
North America 
United States 
Canada 
Latin America 
Mexico 
Brazil 
Argentina 
Others 
Europe 
Germany 
United Kingdom 
France 
Italy 
Spain 
Russia 
Netherland 
Others 
Asia & Pacific 
China 
Japan 
India 
Korea 
Australia 
Southeast Asia 
Indonesia 
Thailand 
Philippines 
Vietnam 
Singapore 
Malaysia 
Others 
Africa & Middle East 
South Africa 
Egypt 
Turkey 
Saudi Arabia 
Iran 
Others

Main types of products 
Drugs for Malaria Market, byyl Aminoalcohol Compounds 
Drugs for Malaria Market, bytifolate Compounds 
Drugs for Malaria Market, bytemisinin Compounds

Drugs for Malaria Market, by Key Consumers 
Prevention 
Treatment 
Other

Complete Report Details@ https://www.wiseguyreports.com/reports/2674823-global-and-united-states-drugs-for-malaria-in-depth-research-report-2017-2022

Major Key Points in Table of Content:

Global and United States Drugs for Malaria In-Depth Research Report 2017-2022 
Chapter One Global Drugs for Malaria Market Overview 
1.1 Global Drugs for Malaria Market Sales Volume Revenue and Price 2012-2017 
1.2 Drugs for Malaria, by l Aminoalcohol Compounds 2012-2017 
1.2.1 Global Drugs for Malaria Sales Market Share by l Aminoalcohol Compounds 2012-2017 
1.2.2 Global Drugs for Malaria Revenue Market Share by l Aminoalcohol Compounds 2012-2017 
1.2.3 Global Drugs for Malaria Price by l Aminoalcohol Compounds 2012-2017 
1.3 Drugs for Malaria, by ifolate Compounds 2012-2017 
1.3.1 Global Drugs for Malaria Sales Market Share by ifolate Compounds 2012-2017 
1.3.2 Global Drugs for Malaria Revenue Market Share by ifolate Compounds 2012-2017 
1.3.3 Global Drugs for Malaria Price by ifolate Compounds 2012-2017 
1.4 Drugs for Malaria, by emisinin Compounds 2012-2017 
1.4.1 Global Drugs for Malaria Sales Market Share by emisinin Compounds 2012-2017 
1.4.2 Global Drugs for Malaria Revenue Market Share by emisinin Compounds 2012-2017 
1.4.3 Global Drugs for Malaria Price by emisinin Compounds 2012-2017 

….

Chapter Eight Top Companies Profile 
8.1 Cipla 
8.1.1 Cipla Company Details and Competitors 
8.1.2 Cipla Key Drugs for Malaria Models and Performance 
8.1.3 Cipla Drugs for Malaria Business SWOT Analysis and Forecast 
8.1.4 Cipla Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.2 Guilin Pharmaceutical 
8.2.1 Guilin Pharmaceutical Company Details and Competitors 
8.2.2 Guilin Pharmaceutical Key Drugs for Malaria Models and Performance 
8.2.3 Guilin Pharmaceutical Drugs for Malaria Business SWOT Analysis and Forecast 
8.2.4 Guilin Pharmaceutical Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.3 IPCA Laboratories 
8.3.1 IPCA Laboratories Company Details and Competitors 
8.3.2 IPCA Laboratories Key Drugs for Malaria Models and Performance 
8.3.3 IPCA Laboratories Drugs for Malaria Business SWOT Analysis and Forecast 
8.3.4 IPCA Laboratories Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.4 GlaxoSmithKline 
8.4.1 GlaxoSmithKline Company Details and Competitors 
8.4.2 GlaxoSmithKline Key Drugs for Malaria Models and Performance 
8.4.3 GlaxoSmithKline Drugs for Malaria Business SWOT Analysis and Forecast 
8.4.4 GlaxoSmithKline Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.5 Mylan Labs 
8.5.1 Mylan Labs Company Details and Competitors 
8.5.2 Mylan Labs Key Drugs for Malaria Models and Performance 
8.5.3 Mylan Labs Drugs for Malaria Business SWOT Analysis and Forecast 
8.5.4 Mylan Labs Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.6 Roche 
8.6.1 Roche Company Details and Competitors 
8.6.2 Roche Key Drugs for Malaria Models and Performance 
8.6.3 Roche Drugs for Malaria Business SWOT Analysis and Forecast 
8.6.4 Roche Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.7 Novartis 
8.7.1 Novartis Company Details and Competitors 
8.7.2 Novartis Key Drugs for Malaria Models and Performance 
8.7.3 Novartis Drugs for Malaria Business SWOT Analysis and Forecast 
8.7.4 Novartis Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.8 Sanofi Aventis 
8.8.1 Sanofi Aventis Company Details and Competitors 
8.8.2 Sanofi Aventis Key Drugs for Malaria Models and Performance 
8.8.3 Sanofi Aventis Drugs for Malaria Business SWOT Analysis and Forecast 
8.8.4 Sanofi Aventis Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin 
8.9 Ajanta Pharma 
8.9.1 Ajanta Pharma Company Details and Competitors 
8.9.2 Ajanta Pharma Key Drugs for Malaria Models and Performance 
8.9.3 Ajanta Pharma Drugs for Malaria Business SWOT Analysis and Forecast 
8.9.4 Ajanta Pharma Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2674823

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: 841 198 5042

Source URL: https://marketersmedia.com/drugs-for-malaria-market-2017-global-trends-market-share-industry-size-growth-opportunities-and-market-forecast-to-2022/281613

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 281613

Integration Software as a Service (iSaaS) Market and Disaster Recovery as a Service (DRaaS) Market Perceived to Develop Substantially by 2022

New Study on “Global Integration Software as a Service (iSaaS) Market” & “Global Disaster Recovery as a Service (DRaaS) Market” added to OrbisResearch.com database.

Dallas, United States – December 26, 2017 /MarketersMedia/ —

“Global Integration Software as a Service (iSaaS) Market Size, Status and Forecast 2022” and “Global Disaster Recovery as a Service (DRaaS) Market Size, Status and Forecast 2022” provides, wherever applicable and relevant, technical data of products, and sheds useful light on expected commercial production dates and current R&D status. This report will help the viewer in Better Decision Making.

Summary (Global Integration Software as a Service (iSaaS) Market):
This report studies the global Integration Software as a Service (iSaaS) market, analyzes and researches the Integration Software as a Service (iSaaS) development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

Request a sample for “Global Integration Software as a Service (iSaaS) Market” @ http://orbisresearch.com/contacts/request-sample/2001268 .

This report focuses on the top players in global market, like:
1. Fujitsu Global
2. Cleo
3. Oracle
4. IBM
5. Dell
6. Jitterbit…
..Continued

Browse the Report “Global Integration Software as a Service (iSaaS) Market” @ http://orbisresearch.com/reports/index/global-integration-software-as-a-service-isaas-market-size-status-and-forecast-2022 .

Market segment by Regions/Countries, this report covers:
• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Application, Integration Software as a Service (iSaaS) can be split into:
• Engineering applications
• Healthcare applications
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Buy “Global Integration Software as a Service (iSaaS) Market” @ http://orbisresearch.com/contact/purchase/2001268 .

Major Points from TOC for “Global Integration Software as a Service (iSaaS) Market”:
1. Industry Overview of Integration Software as a Service (iSaaS)
2. Global Integration Software as a Service (iSaaS) Competition Analysis by Players
3. Company (Top Players) Profiles
4. Global Integration Software as a Service (iSaaS) Market Size by Type and Application (2012-2017)
5. United States Integration Software as a Service (iSaaS) Development Status and Outlook
6. EU Integration Software as a Service (iSaaS) Development Status and Outlook
7. Japan Integration Software as a Service (iSaaS) Development Status and Outlook
8. China Integration Software as a Service (iSaaS) Development Status and Outlook
9. India Integration Software as a Service (iSaaS) Development Status and Outlook
10. Southeast Asia Integration Software as a Service (iSaaS) Development Status and Outlook
11. Market Forecast by Regions, Type and Application (2017-2022)
12. Integration Software as a Service (iSaaS) Market Dynamics
13. Market Effect Factors Analysis
14. Research Finding/Conclusion
15. Appendix

Summary (Global Disaster Recovery as a Service (DRaaS) Market):
This report studies the global Disaster Recovery as a Service (DRaaS) market, analyzes and researches the Disaster Recovery as a Service (DRaaS) development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

Request a sample for “Global Disaster Recovery as a Service (DRaaS) Market” @ http://orbisresearch.com/contacts/request-sample/365171 .

This report focuses on the top players in global market, like:
1. Symantec Corporation
2. Commvault
3. Dell
4. International Business Machines Corporation
5. Oracle Corporation
6. Amazon Web Services
7. Microsoft Corporation
8. VMWare, Inc.
9. Cisco Systems, Inc.
..Continued

Browse the Report “Global Disaster Recovery as a Service (DRaaS) Market” @ http://www.orbisresearch.com/reports/index/global-disaster-recovery-as-a-service-draas-market-size-status-and-forecast-2022 .

Market segment by Regions/Countries, this report covers:
• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Disaster Recovery as a Service (DRaaS) can be split into:
• Private Cloud
• Public Cloud
• Hybrid Cloud

Market segment by Application, Disaster Recovery as a Service (DRaaS) can be split into:
• BFSI
• Retail and Ecommerce
• Government
• IT and Telecom
• Media and Entertainment
• Manufacturing and Logistics
• Education
• Others

Buy “Global Disaster Recovery as a Service (DRaaS) Market” @ http://orbisresearch.com/contact/purchase/365171 .

Major Points from TOC for “Global Disaster Recovery as a Service (DRaaS) Market”:
1. Industry Overview of Disaster Recovery as a Service (DRaaS)
2. Global Disaster Recovery as a Service (DRaaS) Competition Analysis by Players
3. Company (Top Players) Profiles
4. Global Disaster Recovery as a Service (DRaaS) Market Size by Type and Application (2012-2017)
5. United States Disaster Recovery as a Service (DRaaS) Development Status and Outlook
6. EU Disaster Recovery as a Service (DRaaS) Development Status and Outlook
7. Japan Disaster Recovery as a Service (DRaaS) Development Status and Outlook
8. China Disaster Recovery as a Service (DRaaS) Development Status and Outlook
9. India Disaster Recovery as a Service (DRaaS) Development Status and Outlook
10. Southeast Asia Disaster Recovery as a Service (DRaaS) Development Status and Outlook
11. Market Forecast by Regions, Type and Application (2017-2022)
12. Disaster Recovery as a Service (DRaaS) Market Dynamics
13. Market Effect Factors Analysis
14. Research Finding/Conclusion
15. Appendix

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL: https://marketersmedia.com/integration-software-as-a-service-isaas-market-and-disaster-recovery-as-a-service-draas-market-perceived-to-develop-substantially-by-2022/281611

For more information, please visit http://www.orbisresearch.com

Source: MarketersMedia

Release ID: 281611

LED Lighting Market Globally is Prospective to Outstrip US$ 100 Billion by the End of Year 2024

New Study on “Global LED Lighting Market” added to OrbisResearch.com database.

Dallas, United States – December 26, 2017 /MarketersMedia/ —

“Global LED Lighting Market and Forecast By Applications, Regions and Companies” provides, wherever applicable and relevant, technical data of products, and sheds useful light on expected commercial production dates and current R&D status. This report will help the viewer in Better Decision Making.

Global LED lighting market is expected to surpass more than US$ 100 Billion by the end of year 2024. The massive transformation of LED lighting from conventional lighting is happening due to advancement of its features like efficiency, durability, Environmental-friendly and cost effectiveness. All these features of LED lighting is widely recognized and adopted by household, government organisation, industrial sector and commercial segment.

Request a pdf brochure for this report @ http://orbisresearch.com/contacts/request-sample/2001553 .

Types of LED Lighting Market:
1. Residential LED Lighting
2. Office LED Lighting
3. Retail/Shop LED Lighting
4. Hospitality LED Lighting
5. Industrial LED Lighting
6. Outdoor LED Lighting
7. Architectural LED Lighting

Regions Covered in the Report:
1. Europe
2. North America
3. Asia
4. Latin America
5. Middle East & Africa

BRIC countries covered in the Report:
• Brazil
• Russia
• India
• China

Browse the complete report @ http://orbisresearch.com/reports/index/global-led-lighting-market-and-forecast-by-applications-regions-and-companies .

Key Player covered in the Report:
• MLS Co Ltd.
• Philips Lighting
• Osram
• Cree Inc.
• Foshan Electrical & Light

Scope of the Report:
1. Global LED Lighting Market & Forecast: We have defined global LED lighting market by adding all defined regions. Market historical data taken from 2011 to 2016 and forecast from 2017 to 2024.
2. Global LED Lighting Market Share: Report provides global LED lighting market share by Application, by Region and by Companies.
3. Global LED Lighting Market by Application: We have segmented the LED Lighting market into seven applications which are Residential, Office, Retail/Shop, Industrial, Hospitality, Outdoor and Architectural.
4. Global LED Lighting Market by Region: The report consists of five regions: Europe, North America, Asia, Latin America and Middle East & Africa.
..Continued

Global LED lighting market is segmented into seven parts by application: Residential application, Office application, Retail/Shop application, Hospitality application, Industrial application, Outdoor application and Architectural application. The market is also categorized by five regions: Europe, North America, Asia, Latin America and Middle East & Africa. Asia is one of important destination for LED lighting market and has captured highest market share in global LED lighting market.

Purchase the report @ http://orbisresearch.com/contact/purchase/2001553 .

Major Points from TOC:
1. Executive Summary
2. Global LED Lighting Market Analysis – (2011 – 2024)
3. Market Share Analysis – Global LED Lighting
4. By Application – Global LED Lighting Market
5. By Region – Global LED Lighting Market
6. BRIC Countries – LED Lighting Market
7. Public Procurement of Led Lighting in European Union Member States
8. Growth Factors (Due to data confidentiality, growth factors have not been disclosed in this table of contents)
9. Key Challenges (Due to data confidentiality, challenges have not been disclosed in this table of contents)
10. Key Players Analysis

Energy Independence and Climate Change Concern of many Countries enforces towards Paradigm Shift with LEDs Lighting
Rising electricity prices, increasing concern over climate change and great desire of countries to be energy independent are propelling global lighting market into highly-efficient LEDs light sources. In most region of the world, the government has taken significant steps to promote LED lighting like banning incandescent bulb and giving subsidies to the LED lighting manufacturers. Many countries procure LED lighting products like street lighting and several others specialized LEDs lighting for the government organization.

Decreasing Price of LEDs make it Affordable and Cost-Effective
Gradual decreasing prices of LEDs lighting over last five year has increased the penetration rate of Global LED lighting market to a great extent and further this trend will continue in anticipated year till 2019. The adoption of LED lighting in several applications like residential, office, industrial, architectural, Retail shop and so on has increased and it is expected that LED lighting industry will outperform in anticipated year. The initial cost of LED lighting is comparatively high to the traditional incandescents, energy-efficient lightbulbs such as halogen incandescents and compact fluorescent lamps (CFLs). But it cost more cheaper in long-run for example typically use of LED lighting can take 25%-80% less energy than traditional incandescent bulbs, thus saving money and can last 3-25 times longer.

Latest study report “Global LED Lighting Market & Forecast By Applications (Residential, Office, Retail/Shop, Hospitality, Industrial, Outdoor and Architectural) Regions (Europe, North America, Asia, Latin America, Middle East & Africa, BRIC) Companies (MLS Co Ltd., Philips Lighting, Osram, Cree Inc., Foshan Electrical & Light)” provides a detailed and comprehensive insight of the Global LED Lighting Market. This report studies the Global LED lighting market from 7 points.

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL: https://marketersmedia.com/led-lighting-market-globally-is-prospective-to-outstrip-us-100-billion-by-the-end-of-year-2024/281616

For more information, please visit http://www.orbisresearch.com

Source: MarketersMedia

Release ID: 281616